The Advisory Board Company (ABCO) is Downgraded by Raymond James to Mkt Perform

The Advisory Board Company (ABCO) was Downgraded by Raymond James to ” Mkt Perform”. Earlier the firm had a rating of “Outperform ” on the company shares. Raymond James advised their investors in a research report released on Jul 19, 2016.

Many Wall Street Analysts have commented on The Advisory Board Company. The Advisory Board Company was Initiated by Credit Suisse to “Outperform” on Jun 20, 2016. Shares were Reiterated by FBR Capital on May 6, 2016 to “Mkt Perform” and Lowered the Price Target to $ 35 from a previous price target of $40 .

On the company’s financial health, The Advisory Board Company reported $0.46 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on May 5, 2016. Analyst had a consensus of $0.39. The company had revenue of $200.70 million for the quarter, compared to analysts expectations of $201.74 million. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.30 EPS.

The Advisory Board Company closed down -0.25 points or -0.64% at $39 with 2,45,013 shares getting traded on Monday. Post opening the session at $39.26, the shares hit an intraday low of $38.31 and an intraday high of $39.4299 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

In a different news, on Jun 1, 2016, Kelt Kindick (director) purchased 5,000 shares at $32.81 per share price. According to the SEC, on Apr 18, 2016, Cormac F Miller (Chief Product Officer) sold 1,628 shares at $31.65 per share price. On Mar 22, 2016, Hoose Mary Van (Chief Talent Officer) sold 4,172 shares at $30.27 per share price, according to the Form-4 filing with the securities and exchange commission.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

The Advisory Board Company

Leave a Reply

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.